167 related articles for article (PubMed ID: 7798299)
1. Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma.
Montagna M; Menin C; Chieco-Bianchi L; D'Andrea E
J Cancer Res Clin Oncol; 1994; 120(12):732-6. PubMed ID: 7798299
[TBL] [Abstract][Full Text] [Related]
2. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
Davies SM
Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
[TBL] [Abstract][Full Text] [Related]
3. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma.
Albrecht S; von Schweinitz D; Waha A; Kraus JA; von Deimling A; Pietsch T
Cancer Res; 1994 Oct; 54(19):5041-4. PubMed ID: 7923113
[TBL] [Abstract][Full Text] [Related]
4. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
[TBL] [Abstract][Full Text] [Related]
5. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
[TBL] [Abstract][Full Text] [Related]
6. Loss of imprinting in hepatoblastoma.
Rainier S; Dobry CJ; Feinberg AP
Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
Wang WH; Duan JX; Vu TH; Hoffman AR
J Biol Chem; 1996 Nov; 271(44):27863-70. PubMed ID: 8910385
[TBL] [Abstract][Full Text] [Related]
8. Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15.5 in hepatoblastoma.
Albrecht S; Hartmann W; Houshdaran F; Koch A; Gärtner B; Prawitt D; Zabel BU; Russo P; Von Schweinitz D; Pietsch T
Int J Cancer; 2004 Sep; 111(4):627-32. PubMed ID: 15239143
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors.
Chung WY; Yuan L; Feng L; Hensle T; Tycko B
Hum Mol Genet; 1996 Aug; 5(8):1101-8. PubMed ID: 8842727
[TBL] [Abstract][Full Text] [Related]
10. High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma.
Fukuzawa R; Umezawa A; Ochi K; Urano F; Ikeda H; Hata J
Int J Cancer; 1999 Aug; 82(4):490-7. PubMed ID: 10404060
[TBL] [Abstract][Full Text] [Related]
11. Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma.
Casola S; Pedone PV; Cavazzana AO; Basso G; Luksch R; d'Amore ES; Carli M; Bruni CB; Riccio A
Oncogene; 1997 Mar; 14(12):1503-10. PubMed ID: 9136994
[TBL] [Abstract][Full Text] [Related]
12. Genomic imprinting and Wilms' tumor.
Moulton T; Chung WY; Yuan L; Hensle T; Waber P; Nisen P; Tycko B
Med Pediatr Oncol; 1996 Nov; 27(5):476-83. PubMed ID: 8827077
[TBL] [Abstract][Full Text] [Related]
13. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity on chromosome 1 in human hepatoblastoma.
Kraus JA; Albrecht S; Wiestler OD; von Schweinitz D; Pietsch T
Int J Cancer; 1996 Aug; 67(4):467-71. PubMed ID: 8759602
[TBL] [Abstract][Full Text] [Related]
15. Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma.
Honda S; Arai Y; Haruta M; Sasaki F; Ohira M; Yamaoka H; Horie H; Nakagawara A; Hiyama E; Todo S; Kaneko Y
Br J Cancer; 2008 Dec; 99(11):1891-9. PubMed ID: 19034281
[TBL] [Abstract][Full Text] [Related]
16. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
[TBL] [Abstract][Full Text] [Related]
17. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.
Anderson J; Gordon A; McManus A; Shipley J; Pritchard-Jones K
Neoplasia; 1999 Oct; 1(4):340-8. PubMed ID: 10935489
[TBL] [Abstract][Full Text] [Related]
18. Genetic mosaicism at the insulin locus in liver associated with childhood hepatoblastoma.
Simms LA; Reeve AE; Smith PJ
Genes Chromosomes Cancer; 1995 May; 13(1):72-3. PubMed ID: 7541647
[TBL] [Abstract][Full Text] [Related]
19. H19 and IGF-2 allele-specific expression in hepatoblastoma.
Ross JA; Radloff GA; Davies SM
Br J Cancer; 2000 Feb; 82(4):753-6. PubMed ID: 10732739
[TBL] [Abstract][Full Text] [Related]
20. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
